This
page
is
part
of
the
FHIR
Specification
(v3.3.0:
(v3.5.0:
R4
Ballot
2).
#2).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
Patient
Care
Work
Group
|
Maturity Level : 1 | Draft | Use Context : Any |
This is a value set defined by the FHIR project.
Summary
| Defining URL: | http://hl7.org/fhir/ValueSet/adverse-event-causality-assess |
| Version: | 3.5.0 |
| Name: | AdverseEventCausalityAssessment |
| Title: | AdverseEventCausalityAssessment |
| Definition: |
|
| Committee: |
Patient
Care
Work
Group
|
| OID: | 2.16.840.1.113883.4.642.3.840 (for OID based terminology systems) |
| Source Resource | XML / JSON |
This value set is used in the following places:
This value set includes codes from the following code systems:
This
expansion
generated
03
Apr
19
Aug
2018
This value set contains 6 concepts
Expansion
based
on
http://hl7.org/fhir/adverse-event-causality-assess
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess
version
3.3.0
3.5.0
All
codes
from
system
http://hl7.org/fhir/adverse-event-causality-assess
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess
| Code | Display | Definition |
| Certain | Certain |
i)
Event
or
laboratory
test
abnormality,
with
plausible
time
relationship
to
drug
intake
ii)
Cannot
be
explained
by
disease
or
other
drugs
iii)
Response
to
withdrawal
plausible
(pharmacologically,
pathologically)
iv)
Event
definitive
pharmacologically
or
phenomenologically
(i.e.
an
objective
and
specific
medical
disorder
or
a
recognized
pharmacological
phenomenon)
v)
Re-challenge
satisfactory,
if
|
| Probably-Likely | Probably/Likely |
i)
Event
or
laboratory
test
abnormality,
with
reasonable
time
relationship
to
drug
intake
ii)
Unlikely
to
be
attributed
to
disease
or
other
drugs
iii)
Response
to
withdrawal
clinically
reasonable
iv)
Re-challenge
not
|
| Possible | Possible |
i)
Event
or
laboratory
test
abnormality,
with
reasonable
time
relationship
to
drug
intake
ii)
Could
also
be
explained
by
disease
or
other
drugs
iii)
Information
on
drug
withdrawal
may
be
lacking
or
|
| Unlikely | Unlikely |
i)
Event
or
laboratory
test
abnormality,
with
a
time
to
drug
intake
that
makes
a
relationship
improbable
(but
not
impossible)
ii)
Disease
or
other
drugs
provide
plausible
|
| Conditional-Classified | Conditional/Classified |
i)
Event
or
laboratory
test
abnormality
ii)
More
data
for
proper
assessment
needed,
or
iii)
Additional
data
under
|
| Unassessable-Unclassifiable | Unassessable/Unclassifiable |
i)
Report
suggesting
an
adverse
reaction
ii)
Cannot
be
judged
because
information
is
insufficient
or
contradictory
iii)
Data
cannot
be
supplemented
or
|
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |